Linnaeus procures $12 mln Series B


Haddonfield, New Jersey-based Linnaeus Therapeutics Inc, a biopharmaceutical company focused on the development and commercialization of novel, small molecule oncology therapeutics, has raised $12 million in Series B financing. Kairos Ventures led the round with participation from the University of Pennsylvania.

Source: Press Release